诉讼案件概述 - 美国加利福尼亚北区地方法院已对Hims & Hers Health公司(NYSE: HIMS)提起证券集体诉讼 代表在2025年4月29日至2025年6月23日期间购买或获得该公司证券的投资者 [1] - 主要原告截止日期为2025年8月25日 [1][4] 指控内容 - 被告被指控在整个诉讼期间做出重大虚假或误导性陈述 并隐瞒公司业务、运营和前景的重大不利事实 [3] - 具体指控包括：公司参与"欺骗性推广和销售非法的Wegovy仿制品 危及患者安全" [3] - 未向投资者披露：与诺和诺德的合作存在被终止的重大风险 [3] - 由于上述行为 被告对公司业务、运营和前景的积极陈述存在重大误导性或缺乏合理依据 [3] 法律程序信息 - 投资者可在2025年8月25日前申请成为主要原告代表 [4] - 主要原告通常是财务利益最大且符合投资者群体典型特征的投资者或小组 [4] - 主要原告将选择律师代表整个群体 经法院批准后成为主要或集体律师 [4] 律所背景 - Kessler Topaz Meltzer & Check律所在全球范围内处理集体诉讼案件 [5] - 该律所已为欺诈和企业不当行为受害者追回数十亿美元 [5]

NEW YORK, July 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline. SO WHAT: If you purchased Hims common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

NEW YORK, July 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Hims & Hers, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/hims-hers-health-inc-class-action. Investors have until August 25, 2025, to ask th ...

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Hims & Hers Health, Inc. investors who were adversely affected by alleged securities fraud between April 29, 2025 and June 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.co ...

零售投资者兴趣激增 - 公司股票因高卖空比例和社交媒体关注度成为潜在“迷因股”热门候选 [1] - 过去一个月社交媒体讨论量激增近1000% 成为WallStreetBets论坛第12大热门提及股票 [3] - 周五收盘股价上涨0.79%至57.7美元 [8] 卖空压力与轧空潜力 - 公开流通股中33.5%（超6500万股）被卖空 远高于平均水平 [2] - 异常高的卖空比例使其成为零售交易者通过社交媒体协调轧空的理想目标 [2] 基本面与增长潜力 - 分析师预测下一年度每股收益(EPS)将增长178% [5] - 年度营收同比增长111% 用户规模扩张至240万订阅用户 [6] - 零售投资者关注其营销策略 产品创新和增长潜力作为看涨信号 [4] 行业关注度与机构评价 - 交易行为分析师指出零售投资者对创新趋势和品牌建设的敏感度是推动因素 [4] - 分析师认为只要持续保持增长创新和用户体验 零售投资者的参与热情将延续 [7] 潜在风险因素 - 与诺和诺德合作终止及集体诉讼案件引发部分投资者谨慎态度 [6]

美国国会山一个由81名议员组成的跨党派团体在关于GLP-1行动的信函上签名。 他们施压美国食品药品管理局（FDA），要求对混合物与假冒GLP-1药物采取行动。 平价减肥药供应商Hims & Hers Health Inc.（HIMS）股价短线跳水，日内整体转而下跌2.56%。 ...

BENSALEM, Pa., July 25, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at (215) 638-4847 or by email to howardsmith@howardsmithla ...

NEW YORK, July 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Hims & Hers Health, Inc. investors who were adversely affected by alleged securities fraud between April 29, 2025 and June 23, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslr ...

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=157789&from=3 CLASS PERIOD: A ...

NEW YORK, July 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS).Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=157769&from=4CLASS PERIOD: April 29, ...